PatientsLikeMe ™
Join Now! (It’s free)
Already a member? Sign in
Filter by:
patients
Evista Treatment Report
Category: Prescription Drugs
What is Evista?
Evista is a brand name for the drug Raloxifene, an oral selective estrogen receptor modulator which is used in the prevention of osteoporosis in postmenopausal women. Evista is a brand name owned by Eli Lilly.
Read more...
Reported Purpose & Efficacy
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Osteoporosis | 12 | 1 |
|
||||
| Other | 8 | 0 | |||||
| Bone Health | 3 | 1 |
|
||||
| Osteopenia | 2 | 0 | |||||
| Breast Cancer | 1 | 0 | |||||
| slower progression NM symptoms | 1 | 0 |
See all 26 patients currently taking Evista
Mouse over the table for more information
Reported Side Effects
Commonly reported side effects, conditions, and hospitalizations associated with Evista
| Depressed mood | 1 | |
|---|---|---|
| Anxious mood | 1 | |
| Generalized weakness (asthenia) | 1 | |
| Urinary urgency | 1 | |
| Spasms | 1 | |
| Nightmares | 1 | |
| See all 8 reported side effects ▼ | ||
Reported Dosages
| 60 mg daily | ||
|---|---|---|
26
|
||
Reported Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 3 |  |
|
| Side effects too severe | 2 | |
|
| Expense | 1 | |
|
| Personal research | 1 | |
|
| Course of treatment ended | 1 | |
Reported Duration See details about how long patients take this treatment ▼
Reported Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 12, 2012.